PT2812332T - Métodos para a preparação do composto profármaco piperazina inibidor da conjugação ao vih - Google Patents
Métodos para a preparação do composto profármaco piperazina inibidor da conjugação ao vihInfo
- Publication number
- PT2812332T PT2812332T PT137050761T PT13705076T PT2812332T PT 2812332 T PT2812332 T PT 2812332T PT 137050761 T PT137050761 T PT 137050761T PT 13705076 T PT13705076 T PT 13705076T PT 2812332 T PT2812332 T PT 2812332T
- Authority
- PT
- Portugal
- Prior art keywords
- preparation
- methods
- prodrug compound
- hiv attachment
- attachment inhibitor
- Prior art date
Links
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 229940002612 prodrug Drugs 0.000 title 1
- 239000000651 prodrug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/02—Lithium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/098—Esters of polyphosphoric acids or anhydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261596362P | 2012-02-08 | 2012-02-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2812332T true PT2812332T (pt) | 2017-11-15 |
Family
ID=47739512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT137050761T PT2812332T (pt) | 2012-02-08 | 2013-02-06 | Métodos para a preparação do composto profármaco piperazina inibidor da conjugação ao vih |
Country Status (11)
| Country | Link |
|---|---|
| US (9) | US8889869B2 (pt) |
| EP (1) | EP2812332B1 (pt) |
| JP (1) | JP6114314B2 (pt) |
| CN (1) | CN104080785B (pt) |
| BR (1) | BR112014019289A8 (pt) |
| CA (1) | CA2864087A1 (pt) |
| EA (1) | EA024872B1 (pt) |
| ES (1) | ES2644747T3 (pt) |
| MX (1) | MX352320B (pt) |
| PT (1) | PT2812332T (pt) |
| WO (1) | WO2013119625A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7745625B2 (en) * | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| ES2644747T3 (es) | 2012-02-08 | 2017-11-30 | Viiv Healthcare Uk (No. 4) Limited | Procedimientos de preparación de un compuesto de profármaco de piperazina inhibidor de la fijación del VIH |
| US9908882B2 (en) * | 2014-12-18 | 2018-03-06 | ViiV Healthcare UK (No.4) Limited | Process for preparing halogenated azaindole compounds using boroxine |
| CA2971096A1 (en) * | 2014-12-18 | 2016-06-23 | ViiV Healthcare UK (No.4) Limited | A process for preparing halogenated azaindole compounds using pybrop |
| WO2019124107A1 (ja) * | 2017-12-19 | 2019-06-27 | パナソニックIpマネジメント株式会社 | バスバー及び電池積層体 |
| US12157753B2 (en) * | 2019-01-17 | 2024-12-03 | ViiV Healthcare UK (No.4) Limited | Process for preparing Fostemsavir |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6476034B2 (en) * | 2000-02-22 | 2002-11-05 | Bristol-Myers Squibb Company | Antiviral azaindole derivatives |
| IL157029A0 (en) * | 2001-02-02 | 2004-02-08 | Bristol Myers Squibb Co | Azaindoleoxoacetic piperazine derivatives and pharmaceutical compositions containing the same |
| US20040110785A1 (en) * | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US20040063744A1 (en) * | 2002-05-28 | 2004-04-01 | Tao Wang | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| US7745625B2 (en) * | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| US7501419B2 (en) * | 2006-04-25 | 2009-03-10 | Bristol-Myers Squibb Company | 4-Squarylpiperazine derivatives as antiviral agents |
| JP5433690B2 (ja) * | 2008-06-25 | 2014-03-05 | ブリストル−マイヤーズ スクイブ カンパニー | 抗−hiv薬としてのジケト縮合アゾロピペリジンおよびアゾロピペラジン |
| JP5433691B2 (ja) * | 2008-06-25 | 2014-03-05 | ブリストル−マイヤーズ スクイブ カンパニー | Hiv結合阻害剤としてのジケトピペリジン誘導体 |
| WO2012106189A1 (en) | 2011-01-31 | 2012-08-09 | Bristol-Myers Squibb Company | Methods of making hiv attachment inhibitor prodrug compound and intermediates |
| ES2644747T3 (es) | 2012-02-08 | 2017-11-30 | Viiv Healthcare Uk (No. 4) Limited | Procedimientos de preparación de un compuesto de profármaco de piperazina inhibidor de la fijación del VIH |
-
2013
- 2013-02-06 ES ES13705076.1T patent/ES2644747T3/es active Active
- 2013-02-06 BR BR112014019289A patent/BR112014019289A8/pt not_active IP Right Cessation
- 2013-02-06 EP EP13705076.1A patent/EP2812332B1/en active Active
- 2013-02-06 PT PT137050761T patent/PT2812332T/pt unknown
- 2013-02-06 CN CN201380007908.9A patent/CN104080785B/zh not_active Expired - Fee Related
- 2013-02-06 JP JP2014556625A patent/JP6114314B2/ja active Active
- 2013-02-06 WO PCT/US2013/024880 patent/WO2013119625A1/en not_active Ceased
- 2013-02-06 CA CA2864087A patent/CA2864087A1/en not_active Abandoned
- 2013-02-06 EA EA201491446A patent/EA024872B1/ru not_active IP Right Cessation
- 2013-02-06 MX MX2014009279A patent/MX352320B/es active IP Right Grant
- 2013-02-06 US US13/760,526 patent/US8889869B2/en active Active
-
2014
- 2014-10-17 US US14/516,636 patent/US20150038709A1/en not_active Abandoned
- 2014-10-17 US US14/516,669 patent/US9249168B2/en active Active
- 2014-10-17 US US14/516,661 patent/US9394322B2/en active Active
- 2014-10-17 US US14/516,655 patent/US9255113B2/en active Active
- 2014-10-17 US US14/516,664 patent/US9376458B2/en active Active
- 2014-10-17 US US14/516,641 patent/US9243010B2/en active Active
- 2014-10-17 US US14/516,649 patent/US9403821B2/en active Active
-
2016
- 2016-01-04 US US14/986,816 patent/US20160152644A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20160108029A1 (en) | 2016-04-21 |
| EA024872B1 (ru) | 2016-10-31 |
| BR112014019289A2 (pt) | 2017-06-20 |
| US20160152644A1 (en) | 2016-06-02 |
| JP6114314B2 (ja) | 2017-04-12 |
| WO2013119625A1 (en) | 2013-08-15 |
| MX2014009279A (es) | 2014-08-27 |
| US20150038716A1 (en) | 2015-02-05 |
| US20150038717A1 (en) | 2015-02-05 |
| US20150038709A1 (en) | 2015-02-05 |
| US20130203992A1 (en) | 2013-08-08 |
| CN104080785A (zh) | 2014-10-01 |
| EA201491446A1 (ru) | 2014-11-28 |
| JP2015508071A (ja) | 2015-03-16 |
| US20150038711A1 (en) | 2015-02-05 |
| CN104080785B (zh) | 2016-08-31 |
| US9403821B2 (en) | 2016-08-02 |
| US20150038710A1 (en) | 2015-02-05 |
| BR112014019289A8 (pt) | 2017-07-11 |
| ES2644747T3 (es) | 2017-11-30 |
| US8889869B2 (en) | 2014-11-18 |
| US20150038712A1 (en) | 2015-02-05 |
| US9243010B2 (en) | 2016-01-26 |
| US9376458B2 (en) | 2016-06-28 |
| US9255113B2 (en) | 2016-02-09 |
| EP2812332B1 (en) | 2017-08-09 |
| US9249168B2 (en) | 2016-02-02 |
| CA2864087A1 (en) | 2013-08-15 |
| US9394322B2 (en) | 2016-07-19 |
| MX352320B (es) | 2017-11-21 |
| EP2812332A1 (en) | 2014-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2693881T (pt) | Análogos de n-fenilpirimidin-2-amina substituídos como inibidores da axl cinase | |
| LT2892889T (lt) | Inhibitoriaus junginiai | |
| PL3628670T3 (pl) | Postać soli dla inhibicji ezh2 | |
| EP2804479A4 (en) | METALLOENZYME INHIBITOR COMPOUNDS | |
| IL236004A0 (en) | Solid states of an antiviral compound | |
| IL229459B (en) | Use of thiazolide compounds against hiv | |
| EP2894981A4 (en) | METALLO ENZYME INHIBITOR COMPOUNDS | |
| PL2804858T3 (pl) | Związki - inhibitory metaloenzymu | |
| IL226677A (en) | Beta-amyloid production compounds | |
| PT2812332T (pt) | Métodos para a preparação do composto profármaco piperazina inibidor da conjugação ao vih | |
| ZA201409213B (en) | Pro-drug compounds | |
| AP2015008532A0 (en) | Syk kinase inhibitors as treatment for malaria | |
| IL237626A0 (en) | Novel inhibitory compounds of type a10 phosphodiesterase | |
| GB201211019D0 (en) | Inhibitor compounds | |
| EP2680843A4 (en) | DERIVATIVES OF PYRAZOLSUBSTITUTED AMINO-HETEROARYL COMPOUNDS | |
| ZA201502350B (en) | Solid form of hihydro-pyrido-oxazine derivative | |
| SG11201503051QA (en) | Formulations of pyrimidinedione derivative compounds | |
| IL238739A0 (en) | Novel phosphodiesterase type 10a inhibitory compounds | |
| SG10201704303VA (en) | Mixture for the inhibition of melanin biosynthesis | |
| TH1201003653B (th) | สารประกอบพิเพอร์แอซีน ที่มีฤทธิ์ยับยั้ง pgds | |
| TWI561515B (en) | Metalloenzyme inhibitor compounds | |
| GB201211789D0 (en) | Pro-drug compounds | |
| GB201211788D0 (en) | Pro-drug compounds | |
| IL236946A0 (en) | A10-type phosphodiesterase inhibitory compounds | |
| GB201208751D0 (en) | Anti-malarial compounds |